The structure of nirmatrelvir MTBE solvate, C23H32F3N5O4·C5H12O, at 150 K has monoclinic (P21) symmetry. The asymmetric unit contains one nirmatrelvir molecule and one methyl tert-butyl ether solvent molecule. The extended structure consists of N—H⋯O hydrogen bonds that create [010] chains. Crystals of the title compound were grown from various methyl tert-butyl ether–methanol solvent mixtures, with crystal morphology dependent upon the mixture ratio.
Jared P. Smit, Dale K. Purcell, David A. Engers, Pamela A. Smith, Haley C. Bauserb, and Adrian Radoceab
Improved Pharma, LLC, 1281 Win Hentschel Blvd., West Lafayette, IN 47906, USA, and bVarda Space Industries, 225 S. Aviation Blvd., El Segundo, CA 90245, USA
Correspondence e-mail: jared.smit@improvedpharma.com
Edited by J. Reibenspies, Texas A & M University, USA (Received 2 April 2026; accepted 10 April 2026; online 14 April 2026)